Gene · 9020
Papers3,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of the immune-related biomarkers in Behcet's disease by plasma proteomic analysis. | Arthritis Res Ther | 2023 | 37264476 | PubTator, text mining | PubMed |
| Vitamin C: From nutrition to oxygen sensing and epigenetics. | Redox Biol | 2023 | 37263060 | PubTator, text mining | PubMed |
| Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patients. | PLoS One | 2023 | 37253035 | PubTator, text mining | PubMed |
| Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion. | Pathogens | 2023 | 37242405 | PubTator, text mining | PubMed |
| CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma. | Int J Mol Sci | 2023 | 37240076 | PubTator, text mining | PubMed |
| Mutations in the Vicinity of the IRAK3 Guanylate Cyclase Center Impact Its Subcellular Localization and Ability to Modulate Inflammatory Signaling in Immortalized Cell Lines. | Int J Mol Sci | 2023 | 37239919 | PubTator, text mining | PubMed |
| A ZFYVE21-Rubicon-RNF34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells. | Nat Commun | 2023 | 37225719 | PubTator, text mining | PubMed |
| RANKL inhibition: a new target of treating diabetes mellitus? | Ther Adv Endocrinol Metab | 2023 | 37223831 | PubTator, text mining | PubMed |
| Cancer cachexia: molecular mechanisms and treatment strategies. | J Hematol Oncol | 2023 | 37217930 | PubTator, text mining | PubMed |
| Helicobacter pylori regulates stomach diseases by activating cell pathways and DNA methylation of host cells. | Front Cell Dev Biol | 2023 | 37215092 | PubTator, text mining | PubMed |
| Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications. | Explor Target Antitumor Ther | 2023 | 37205308 | PubTator, text mining | PubMed |
| miR‑27a‑3p upregulation by p65 facilitates cervical tumorigenesis by increasing TAB3 expression and is involved in the positive feedback loop of NF‑κB signaling. | Oncol Rep | 2023 | 37203408 | PubTator, text mining | PubMed |
| Hexokinases in cancer and other pathologies. | Cell Insight | 2023 | 37192912 | PubTator, text mining | PubMed |
| The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer. | Biomedicines | 2023 | 37189677 | PubTator, text mining | PubMed |
| Advances in the knowledge on the role of apoptosis repressor with caspase recruitment domain in hemorrhagic stroke. | J Intensive Med | 2023 | 37188117 | PubTator, text mining | PubMed |
| Antibody-based cancer immunotherapy by targeting regulatory T cells. | Front Oncol | 2023 | 37182149 | PubTator, text mining | PubMed |
| Modulation of redox-sensitive transcription factors with polyphenols as pathogenetically grounded approach in therapy of systemic inflammatory response. | Heliyon | 2023 | 37180884 | PubTator, text mining | PubMed |
| Antitumor effects and potential mechanisms of aconitine based on preclinical studies: an updated systematic review and meta-analysis. | Front Pharmacol | 2023 | 37180714 | PubTator, text mining | PubMed |
| Amino-Pyrazoles in Medicinal Chemistry: A Review. | Int J Mol Sci | 2023 | 37175540 | PubTator, text mining | PubMed |
| NF-κB-Inducing Kinase Provokes Insulin Resistance in Skeletal Muscle of Obese Mice. | Inflammation | 2023 | 37171694 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9020/papers?page=16